Clinical Study Results
Research Sponsor: AstraZeneca
Drug Studied: Olaparib
Study Purpose: This study was done to learn how well olaparib
works in women with advanced ovarian
cancer who had received chemotherapy
that had worked partly or completely
Protocol Number: D0816C00020
Thank you
Thank you for taking part in the clinical study for the study drug olaparib.
You and all of the participants helped researchers learn more about olaparib to help women with
ovarian cancer who had received chemotherapy previously that had either removed their ovarian
cancer completely or partly.
AstraZeneca sponsored this study and believes it is important to share the results of the study
with you and the public. An independent non-profit organization called CISCRP helped prepare
this summary of the study results for you. We hope it helps you understand and feel proud of
your important role in medical research.
If you participated in the study and have questions about the results, please speak with the
study doctor or staff at your study site.
1